|
|
| Line 1: |
Line 1: |
| __NOEDITSECTION____NOTOC__
| | {{Details0|Metoprolol succinate (tablet)}} |
| {{CMG}} | | {{Details0|Metoprolol tartrate (injection)}} |
| | | {{Details0|Metoprolol tartrate (tablet)}} |
| ===[[Metoprolol succinate|Metoprolol succinate]] ([[Toprol XL]], [[Toprolxl XL]])===
| |
| ===[[Metoprolol tartrate|Metoprolol tartrate]] ([[Lopressor]])===
| |
| <!--
| |
| ===[[Metoprolol succinate/Hydrochlorothiazide|Metoprolol succinate/Hydrochlorothiazide]] ([[Dutoprol]])===
| |
| | |
| ===[[Metoprolol tartrate/Arginine|Metoprolol tartrate/Arginine]] ([[Hypertensolol]])===
| |
| ===[[Metoprolol tartrate/Hydrochlorothiazide|Metoprolol tartrate/Hydrochlorothiazide]] ([[Lopressor HCT]])===
| |
| -->
| |
| ==Overview==
| |
| | |
| Metoprolol is a competitive, [[Beta-1 adrenergic receptor|β<sub>1</sub>]]-selective (cardioselective) [[beta blocker|blocker]] used in treatment of [[angina pectoris]], [[hypertension]], [[arrhythmia]], and [[migraine]]. Common adverse reactions include [[bradyarrhythmia]], [[heart block]], [[heart failure]], [[hypotension]], [[pruritus]], [[rash]], [[constipation]], [[diarrhea]], [[indigestion]], [[nausea]], [[dizziness]], [[fatigue]], [[headache]], [[depression]], [[dyspnea]], and [[wheezing]].
| |
| | |
| The active substance metoprolol is employed either as ''metoprolol [[succinic acid|succinate]]'' or as ''metoprolol [[tartrate]]''. The [[tartrate]] is an immediate-release and the [[succinic acid|succinate]] is an extended-release [[Pharmaceutical formulation|formulation]].
| |
| | |
| {{Beta blockers}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drug]]
| |
| [[Category:Beta blockers]]
| |
| [[Category:Antiarrhythmic agents]]
| |